Iovance Biotherapeutics (IOVA) Selling, General & Administrative (2015 - 2026)

Iovance Biotherapeutics (IOVA) Selling, General & Administrative (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 582.20 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 662.10 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1.13 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 110.21 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 593.21 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 2,715.95
7 Royalty Pharma 33.72 Bn 35.84 Bn - 161.89 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 347.92 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 247.47 Mn
10 Iovance Biotherapeutics 3.16 Bn 2.86 Bn 55.72 Mn 39.27 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 39.27 Mn
Mar 31, 2026 38.95 Mn
Dec 31, 2025 36.40 Mn
Sep 30, 2025 34.56 Mn
Jun 30, 2025 37.70 Mn
Mar 31, 2025 43.80 Mn
Dec 31, 2024 42.32 Mn
Sep 30, 2024 39.34 Mn
Jun 30, 2024 39.57 Mn
Mar 31, 2024 31.39 Mn
Dec 31, 2023 29.09 Mn
Sep 30, 2023 26.96 Mn
Jun 30, 2023 21.93 Mn
Mar 31, 2023 28.12 Mn
Dec 31, 2022 26.46 Mn
Sep 30, 2022 27.89 Mn
Jun 30, 2022 26.33 Mn
Mar 31, 2022 23.41 Mn
Dec 31, 2021 23.85 Mn
Sep 30, 2021 20.89 Mn